The deal, disclosed to Congress only after intense pressure from the House Appropriations Committee, specifically targets the National Institute of Allergy and Infectious Diseases. With an annual budget of roughly $7 billion, the institute serves as a prime source for research into HIV, influenza, and tuberculosis. Lawmakers argue the Pentagon is effectively bypassing congressional oversight to secure cash for a war effort that has already cost an estimated $37.5 billion.
Democratic leaders, including Senator Patty Murray, are demanding the immediate termination of the agreement. Critics contend the administration is prioritizing military expansion—currently backed by an annual budget exceeding $1.1 trillion—over critical biomedical research. While a spokesperson for the Trump administration claimed the funds would facilitate responses to public health emergencies, advocates like Leslie Dach of Protect Our Care dismissed the justification, calling the arrangement a budgetary shell game designed to mask the true costs of the Iran campaign.

Comments (0)
No comments yet. Be the first!